Araki T, Ueda M, Ogawa K, Tsuji T
Department of Medicine, Shigei Medical Research Hospital, Okayama, Japan.
Int J Pancreatol. 1992 Dec;12(3):263-9. doi: 10.1007/BF02924366.
To clarify a possible cause of hyperamylasemia in end-stage renal disease (ESRD), histological studies were performed on the pancreatic glands of twenty-seven autopsied patients with ESRD who had received long-term hemodialysis. The findings were compared with those in a similar number of age-matched control subjects. Histological evidence of pancreatitis was found in 51.9% of the ESRD patients as compared with 14.8% in the controls (p < 0.005). The pancreatitis was chronic in nature in 85.7% of the ESRD patients showing changes of pancreatitis. Secretin administration to an additional group of twelve patients with ESRD induced an elevation in the activities of both total and P-type serum amylase in only one patient. These findings suggest that although histological pancreatic alterations are common in patients with ESRD, they are probably not responsible for the P-type hyperamylasemia frequently found in such patients.
为了阐明终末期肾病(ESRD)患者高淀粉酶血症的一个可能原因,我们对27例接受长期血液透析的ESRD尸检患者的胰腺进行了组织学研究。将研究结果与相同数量的年龄匹配对照受试者的结果进行比较。ESRD患者中有51.9%发现胰腺炎的组织学证据,而对照组为14.8%(p<0.005)。在出现胰腺炎改变的ESRD患者中,85.7%的胰腺炎为慢性。对另外12例ESRD患者给予促胰液素后,仅1例患者的总血清淀粉酶和P型血清淀粉酶活性升高。这些发现表明,尽管ESRD患者胰腺组织学改变很常见,但它们可能不是这类患者中常见的P型高淀粉酶血症的原因。